|

Foralumab Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 2: 1

Top Sponsors

  • Tiziana Life Sciences LTD1

Indications

  • Secondary Progressive Multiple Sclerosis1
  • Multiple Sclerosis1

North Haven, Connecticut1 trial

A Study of Nasal Foralumab in Non-Active Secondary Progressive Multiple Sclerosis Patients

Yale

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.